نتایج جستجو برای: implantable cardioverter defibrillator

تعداد نتایج: 19988  

Journal: :European heart journal 2006
Matteo Renzulli Giancarlo Piovaccari Rossella Fattori

Hess J. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006;107:30–35. 9. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. ...

Journal: :Revista espanola de cardiologia 2013
Javier Alzueta José María Fernández

INTRODUCTION AND OBJECTIVES To summarize the findings of the Spanish Implantable Cardioverter-defibrillator Registry for 2012 compiled by the Electrophysiology and Arrhythmias Section of the Spanish Society of Cardiology. METHODS Prospective data recorded voluntarily on single-page questionnaires were sent to the Spanish Society of Cardiology by each implantation team. RESULTS Overall, 4216...

Journal: :Circulation 2011
Avi Fischer

The implantable cardioverter-defibrillator lead has undergone numerous design and manufacturing changes over the last 25 years aimed at improving patient care and outcomes. It is widely accepted that implantable cardioverterdefibrillator leads, similar to pacemaker leads, have a finite life. The design of an implantable cardioverter-defibrillator lead is more complex than that of a pacemaker le...

2017
Mitsuhiro Fukata Takeshi Arita Hideki Kadota Keita Odashiro Toru Maruyama Koichi Akashi

Introduction A subcutaneous implantable cardioverter-defibrillator (S-ICD) is now being used as an alternative to a transvenous implantable cardioverter-defibrillator (TV-ICD). Because the location of the device in the body differs between S-ICD and TV-ICD, ICD-related complications need to be managed in a device-specific manner. Therefore, therapeutic strategies for infected wounds may differ ...

2016
Yusuke Kondo Marehiko Ueda Yoshio Kobayashi Joerg O. Schwab

There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades. CIED infection represents a serious complication after CIED implantation and is associated with significant morbidity and mortality. Recently, newly advanced technologies have offered attractive and suitable therapeutic alternatives. Notably, ...

2018
Dirk Skowasch Steven Ringquist Georg Nickenig René Andrié

BACKGROUND Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation. OBJECTIVE We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis patients. METHODS A retrospective review of the commercial database identified cardiac sarcoidosis patients who wore the w...

2017
Marcello Disertori Michela Masè Marta Rigoni Giandomenico Nollo Eloisa Arbustini Flavia Ravelli

Citation: Disertori M, Masè M, Rigoni M, Nollo G, Arbustini E and Ravelli F (2017) Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients. Front. Physiol. 8:873. doi: 10.3389/fphys.2017.00873 Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-T...

Journal: :Journal of the American Heart Association 2016
Christine I Nichols Joshua G Vose Suneet Mittal

BACKGROUND Inadvertent damage to leads for transvenous pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator-replacement procedures. We sought to estimate the incidence and costs associated with transvenous lead damage following cardiac implantable electronic device replacement. METHODS ...

Journal: :Circulation 2013
Frédéric Sacher Vincent Probst Philippe Maury Dominique Babuty Jacques Mansourati Yuki Komatsu Christelle Marquie Antonio Rosa Abou Diallo Romain Cassagneau Claire Loizeau Raphael Martins Michael E Field Nicolas Derval Shinsuke Miyazaki Arnaud Denis Akihiko Nogami Philippe Ritter Jean-Baptiste Gourraud Sylvain Ploux Anne Rollin Adlane Zemmoura Dominique Lamaison Pierre Bordachar Bertrand Pierre Pierre Jaïs Jean-Luc Pasquié Mélèze Hocini François Legal Pascal Defaye Serge Boveda Yoshito Iesaka Philippe Mabo Michel Haïssaguerre

BACKGROUND Implantable cardioverter-defibrillator indications in Brugada syndrome remain controversial, especially in asymptomatic patients. Previous outcome data are limited by relatively small numbers of patients or short follow-up durations. We report the outcome of patients with Brugada syndrome implanted with an implantable cardioverter-defibrillator in a large multicenter registry. METH...

2015
Hamid Ghanbari Brahmajee K. Nallamothu Yongfei Wang Jeptha P. Curtis

BACKGROUND Management of antithrombotic agents after implantable cardioverter defibrillator implantation is challenging, particularly among patients with atrial fibrillation and coronary artery disease. METHODS AND RESULTS Using data from National Cardiovascular Data Registry(®) Implantable Cardioverter Defibrillator Registry(™) linked with Medicare claims data, we identified 25 180 patients ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید